Mereo BioPharma licenses alvelestat to Sentynl for U.S. market
Go back to Mereo BioPharma licenses alvelestat to Sentynl for U.S. market| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.01 | |||
| Open | $0.30 | 52 Week Low | $0.00 | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $-0.02 | |||
| Volume | 668,173 | |||||
